In:
Neurodegenerative Disease Management, Future Medicine Ltd, Vol. 10, No. 6 ( 2020-12), p. 369-382
Abstract:
Aim: This discrete choice experiment aimed to assess patients' preferences for treatment attributes in multiple sclerosis (MS). Patients & methods: Patients with relapsing-remitting MS completed an online survey assessing treatment preferences. Descriptive statistical analysis and discrete choice hierarchical Bayesian modeling were performed. Results: Across the overall sample (n = 485), dosing regimen, efficacy and safety were equally important. Within the whole sample, and among those diagnosed 〈 10 years ago, intravenous infusion ≤3 times/year was the preferred dosing regimen; among patients diagnosed ≥10 years ago it was preferred equally to oral treatments. Patients were more willing to accept frequent but mild over rare but severe side effects. Conclusion: Several factors influence patient preferences for MS treatments and must be considered in patient-centered care.
Type of Medium:
Online Resource
ISSN:
1758-2024
,
1758-2032
DOI:
10.2217/nmt-2020-0034
Language:
English
Publisher:
Future Medicine Ltd
Publication Date:
2020
